Talimogene laherparepvec pseudolymphomatous reaction mimicking metastatic melanoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cutaneous Pathology"
DOI: 10.1111/cup.14094
Abstract: Talimogene laherparepvec (TVEC) is a genetically modified herpes simplex virus‐1 approved as an intralesional oncolytic immunotherapy for the treatment of advanced melanoma. Cutaneous reactions at the site of injection may mimic recurrent or progressive melanoma;… read more here.
Keywords: melanoma; talimogene laherparepvec; reaction mimicking; pseudolymphomatous reaction ... See more keywords